Fish oil treatment for kidney transplant recipients: A meta-analysis of randomized controlled trials

Transplantation

Volumn 83, Issue 7, 2007, Pages 831-838

  Lim, Andy K H ^a   Manley, Karen J ^b   Roberts, Matthew A ^b   Fraenkel, Margaret B ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Calcineurin inhibitor; Fish oil; HMG CoA reductase inhibitors; Kidney transplantation; Omega 3 fatty acids

Indexed keywords

CALCINEURIN INHIBITOR; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PLACEBO; STATIN;

BLOATING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DIARRHEA; DIASTOLIC BLOOD PRESSURE; EMBASE; FISHY AFTERTASTE; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; LOW DRUG DOSE; MEDLINE; META ANALYSIS; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SUPPLEMENTATION; SYSTEMATIC REVIEW;

CADAVER; FISH OILS; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; RESEARCH DESIGN; TISSUE DONORS;

EID: 34247566018     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000258613.32993.84     Document Type: Review

References (43)

1. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000; 71: 179S.
2. Brenna JT. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002; 5: 127.
3. Psota T, Gebauer S, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 2006; 98: 3i.
4. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ 2004; 328: 30.
5. Ader JL, Rostaing L. Cyclosporin nephrotoxicity: pathophysiology and comparison with FK-506. Curr Opin Nephrol Hypertens 1998; 7: 539.
6. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
7. McDonald S, Russ G. 26th report of the ANZDATA registry: Deaths. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2003: 15.
8. Braun W. The medical management of renal transplant recipients. In: Johnson R, Feehally J, eds. Comprehensive clinical nephrology. St. Louis: Mosby, 2003: 1105.
9. Norris SH. Renal eicosanoids. Semin Nephrol 1990; 10: 64.
10. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265.
11. Endres S, Meydani SN, Ghorbani R, et al. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 1993; 54: 599.
12. Ford HR, Hoffman RA, Tweardy DJ, et al. Evidence that production of interleukin 6 within the rejecting allograft coincides with cytotoxic T lymphocyte development. Transplantation 1991; 51: 656.
13. Ford HR, Hoffman RA, Wang SA, Simmons RL. Profile of cytokine production within the rejecting allograft. Transplant Proc 1991; 23: 251.
14. Noronha IL, Hartley B, Cameron JS, Waldherr R. Detection of IL-1 beta and TNF-alpha message and protein in renal allograft biopsies. Transplantation 1993; 56: 1026.
15. Noronha IL, Weis H, Hartley B, et al. Expression of cytokines, growth factors, and their receptors in renal allograft biopsies. Transplant Proc 1993; 25: 917.
16. Yard BA, Kooymans-Couthino M, Paape ME, et al. Analysis of cytokine production by graft-infiltrating cells isolated from rejecting renal allografts. Transplantation 1994; 57: 153.
17. Vandenbroecke C, Caillat-Zucman S, Legendre C, et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991; 51: 602.
18. Kelley VE, Kirkman RL, Bastos M, et al. Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine. Transplantation 1989; 48: 98.
19. Otto DA, Kahn DR, Hamm MW, et al. Improved survival of heterotopic cardiac allografts in rats with dietary n-3 polyunsaturated fatty acids. Transplantation 1990; 50: 193.
20. Sweny P, Wheeler DC, Lui SF, et al. Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection. Nephrol Dial Transplant 1989; 4: 1070.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557.
22. Bennett WM, Carpenter CB, Shapiro ME, et al. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebocontrolled study. Transplantation 1995; 59: 352.
23. Homan van der Heide JJ, Bilo HJ, Tegzess AM, Donker AJ. The effects of dietary supplementation with fish oil on renal function in cyclosporine-treated renal transplant recipients. Transplantation 1990; 49: 523.
24. Schut N, Bilo H, Popp-Snijders C, et al. Erythrocyte deformability, endothelin levels, and renal function in cyclosporin-treated renal transplant recipients: effects of intervention with fish oil and corn oil. Scand J Clin Lab Invest 1993; 53: 499.
25. Hernandez D, Guerra R, Milena A, et al. Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: a randomized placebo-controlled study. Nephrol Dial Transplant 2002; 17: 897.
26. Homan van der Heide JJ, Bilo HJ, Donker AJ, et al. Dietary supplementation with fish oil modifies renal reserve filtration capacity in postoperative, cyclosporin A-treated renal transplant recipients. Transpl Int 1990; 3: 171.
27. Homan van der Heide JJ, Bilo HJ, Donker AJ, et al. The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients. Transplantation 1992; 54: 257.
28. van der Heide JJ, Bilo HJ, Donker JM, et al. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants. N Engl J Med 1993; 329: 769.
29. Busnach G, Stragliotto E, Minetti E, et al. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study. J Nephrol 1998; 11: 87.
30. Kooijmans-Coutinho MF, Rischen-Vos J, Hermans J, et al. Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown. J Am Soc Nephrol 1996; 7: 513.
31. Santos J, Queiros J, Silva F, et al. Effects of fish oil in cyclosporine-treated renal transplant recipients. Transplant Proc 2000; 32: 2605.
32. Berthoux FC, Guerin C, Burgard G, et al. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation. Transplant Proc 1992; 24: 2578.
33. Rodriguez A, De B, Gonzalez P, et al. Tratamiento de la dislipemia postrasplante renal: efecto comparativo de la lovastatina y acidos grasos pliinsaturados omega-3. Nefrologia 1997; 17: 49.
34. Castro R, Queiros J, Fonseca I, et al. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil. Nephrol Dial Transplant 1997; 12: 2140.
35. Tatsioni A, Chung M, Sun Y, et al. Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2005; 16: 2462.
36. Corda C, Mounie J, Mousson C, et al. Randomised double blind study of the possible protective effects by fish oil polyunsaturated omega 3 fatty acids, against cyclosporine A (Cya) induced renal damage in kidney transplants. Fundam Clin Pharmacol 1992; 6: 223.
37. Urakaze M, Hamazaki T, Yano S, et al. Effect of fish oil concentrate on risk factors of cardiovascular complications in renal transplantation. Transplant Proc 1989; 21: 2134.
38. Urakaze M, Hamazaki T, Kashiwabara H, et al. Favorable effects of fish oil concentrate on risk factors for thrombosis in renal allograft recipients. Nephron 1989; 53: 102.
39. Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006; 189: 19.
40. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006; 332: 752.
41. Wang C, Harris WS, Chung M, et al. n-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006; 84: 5.
42. Maachi K, Berthoux P, Burgard G, et al. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc 1995; 27: 846.
43. Yoa R, Corda C, Rapin J, et al. Hemorheological benefits of omega-3 polyunsaturated fatty acids on erythrocyte deformability in renal transplanted patients. Clin Hemorheol 1994; 14: 663.